Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A15839 | 28687713 | Clin Sci (Lond) | TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival. | 2017 | Details |
| A15843 | 28686220 | Children (Basel) | The Association between Non-Alcoholic Fatty Liver Disease and Cardiovascular Risk in Children. | 2017 | Details |
| A15845 | 28685623 | Expert Opin Pharmacother | Cardiovascular disease prevention strategies for type 2 diabetes mellitus. | 2017 | Details |
| A15846 | 28685131 | Can J Gastroenterol Hepatol | Relationship between Nonalcoholic Fatty Liver Disease and Vitamin D Nutritional Status in Extreme Obesity. | 2017 | Details |
| A15849 | 28683283 | Cell Metab | Inhibition of IKKɛ and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 Diabetes. | 2017 | Details |
| A15850 | 28681988 | Diabetes Obes Metab | Effect of liraglutide on ectopic fat in polycystic ovary syndrome: A randomized clinical trial. | 2017 | Details |
| A15852 | 28680417 | Front Endocrinol (Lausanne) | Alternative RNA Splicing in the Pathogenesis of Liver Disease. | 2017 | Details |
| A15857 | 28678821 | PLoS One | A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice. | 2017 | Details |
| A15859 | 28678199 | Int J Mol Sci | The Role of Growth Hormone and Insulin-Like Growth Factor-I in the Liver. | 2017 | Details |
| A15870 | 28676332 | Respir Physiol Neurobiol | Circulating exosomes in obstructive sleep apnea as phenotypic biomarkers and mechanistic messengers of end-organ morbidity. | 2017 | Details |
| A15872 | 28676026 | Curr Vasc Pharmacol | A Critical Approach of Guideline Therapeutic Recommendations for NAFLD. | 2018 | Details |
| A15874 | 28676024 | Curr Vasc Pharmacol | NAFLD-NASH: An Under-Recognized Epidemic. | 2018 | Details |
| A15876 | 28676019 | Curr Vasc Pharmacol | Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk. | 2018 | Details |
| A15877 | 28676018 | Curr Vasc Pharmacol | Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease? | 2018 | Details |
| A15881 | 28673968 | Proc Natl Acad Sci U S A | Hepatic ZIP14-mediated zinc transport is required for adaptation to endoplasmic reticulum stress. | 2017 | Details |
| A15888 | 28670394 | Am J Transl Res | PFP alleviates nonalcoholic steatohepatitis fatty liver in both Apo E-/- mice and Changliver cell[S]. | 2017 | Details |
| A15890 | 28669328 | Curr Vasc Pharmacol | Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome? | 2018 | Details |
| A15894 | 28666456 | Lipids Health Dis | Effect of cholecystectomy on hepatic fat accumulation and insulin resistance in non-obese Hispanic patients: a pilot study. | 2017 | Details |
| A15896 | 28665032 | Hepatology | Sex differences between parental pregnancy characteristics and nonalcoholic fatty liver disease in adolescents. | 2017 | Details |
| A15899 | 28662945 | J Pediatr | Nonalcoholic Fatty Liver Disease in Italian Children with Down Syndrome: Prevalence and Correlation with Obesity-Related Features. | 2017 | Details |
| A15904 | 28659437 | Sci Transl Med | Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β. | 2017 | Details |
| A15906 | 28658094 | Medicine (Baltimore) | Multimorbidity and polypharmacy in diabetic patients with NAFLD: Implications for disease severity and management. | 2017 | Details |
| A15908 | 28657604 | Nutrients | Fruit Fiber Consumption Specifically Improves Liver Health Status in Obese Subjects under Energy Restriction. | 2017 | Details |
| A15909 | 28655985 | Ann Gastroenterol | Circulating adipokines in children with nonalcoholic fatty liver disease: possible noninvasive diagnostic markers. | 2017 | Details |
| A15911 | 28655714 | Am J Physiol Endocrinol Metab | Epidermal growth factor receptor restoration rescues the fatty liver regeneration in mice. | 2017 | Details |
| A15912 | 28655690 | Pak J Pharm Sci | Metformin HCl has curative effect on rebuilding of ventricular diastolic functions in high-fat-diet fed rats. | 2017 | Details |
| A15917 | 28652891 | World J Hepatol | Non-alcoholic fatty liver disease: An expanded review. | 2017 | Details |
| A15920 | 28652650 | World J Gastroenterol | Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease. | 2017 | Details |
| A15923 | 28650518 | Liver Int | A simple in silico strategy identifies candidate biomarkers for the diagnosis of liver fibrosis in morbidly obese subjects. | 2017 | Details |
| A15926 | 28647765 | Abdom Radiol (NY) | Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis. | 2018 | Details |
| A15929 | 28647324 | Trends Endocrinol Metab | AMPK as a Therapeutic Target for Treating Metabolic Diseases. | 2017 | Details |
| A15934 | 28645738 | J Hepatol | Human germline hedgehog pathway mutations predispose to fatty liver. | 2017 | Details |
| A15937 | 28643888 | Mol Nutr Food Res | Combination of citrus polymethoxyflavones, green tea polyphenols, and Lychee extracts suppresses obesity and hepatic steatosis in high-fat diet induced obese mice. | 2017 | Details |
| A15940 | 28642059 | J Hepatol | New trends on obesity and NAFLD in Asia. | 2017 | Details |
| A15942 | 28641788 | Metabolism | Non-alcoholic fatty liver disease: A sign of systemic disease. | 2017 | Details |
| A15945 | 28641570 | Endocr Metab Immune Disord Drug Targets | 1h Post-load Blood Glucose in the Identification of Proatherogenic Cardiometabolic Profile in Obesity. | 2017 | Details |
| A15947 | 28640662 | Gut Microbes | Using probiotics in clinical practice: Where are we now? A review of existing meta-analyses. | 2017 | Details |
| A15949 | 28640216 | Nutrients | A Branched-Chain Amino Acid-Related Metabolic Signature Characterizes Obese Adolescents with Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A15951 | 28639757 | Rev Med Suisse | [Ketogenic diets : the miraculous solution ?] | 2017 | Details |
| A15958 | 28637408 | Curr Vasc Pharmacol | Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non- Alcoholic Steatohepatitis. | 2018 | Details |
| A15959 | 28637104 | Korean J Gastroenterol | [Treatment Options in Non-alcoholic Fatty Liver Disease]. | 2017 | Details |
| A15960 | 28637103 | Korean J Gastroenterol | [The Development of Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease]. | 2017 | Details |
| A15961 | 28637102 | Korean J Gastroenterol | [The Progression of Liver Fibrosis in Non-alcoholic Fatty Liver Disease]. | 2017 | Details |
| A15963 | 28636830 | Appl Physiol Nutr Metab | Attenuation of hepatic steatosis by purple sweet potato colour is associated with blocking Src/ERK/C/EBPβ signalling in high-fat-diet-treated mice. | 2017 | Details |
| A15965 | 28635586 | Gene Expr | GC-1: A Thyromimetic With Multiple Therapeutic Applications in Liver Disease. | 2017 | Details |
| A15975 | 28630692 | J Nutr Sci | Liver fat: a relevant target for dietary intervention? Summary of a Unilever workshop. | 2017 | Details |
| A15977 | 28629152 | Children (Basel) | The Association between Pediatric NAFLD and Common Genetic Variants. | 2017 | Details |
| A15984 | 28627213 | Nutr Hosp | Nonalcoholic fatty liver disease (NAFLD) pathophysiology in obese children and adolescents: update | 2017 | Details |
| A15991 | 28623125 | Biochem Biophys Res Commun | Chronic intermittent hypoxia induces liver fibrosis in mice with diet-induced obesity via TLR4/MyD88/MAPK/NF-kB signaling pathways. | 2017 | Details |
| A15996 | 28621339 | Nat Rev Endocrinol | Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance. | 2017 | Details |
| A16001 | 28619255 | J Hepatol | Infant nutrition and maternal obesity influence the risk of non-alcoholic fatty liver disease in adolescents. | 2017 | Details |
| A16002 | 28618991 | Curr Med Chem | Effects of Polyphenolic Derivatives on Heme Oxygenase-System in Metabolic Dysfunctions. | 2018 | Details |
| A16004 | 28616057 | J Res Med Sci | Serum omentin-1, vaspin, and apelin levels and central obesity in patients with nonalcoholic fatty liver disease. | 2017 | Details |
| A16005 | 28615690 | Sci Rep | Cathepsin D regulates lipid metabolism in murine steatohepatitis. | 2017 | Details |
| A16009 | 28612634 | Expert Rev Gastroenterol Hepatol | Lysosomal acid lipase deficiency: a form of non-obese fatty liver disease (NOFLD). | 2017 | Details |
| A16010 | 28612550 | Sichuan Da Xue Xue Bao Yi Xue Ban | [Serum Wnt5a and Its Associations with Liver Steatosis and Fibrosis in Overweight and Obese People]. | 2017 | Details |
| A16012 | 28612285 | J Endocrinol Invest | Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis. | 2017 | Details |
| A16019 | 28608557 | J Food Sci | Salicornia Extract Ameliorates Salt-Induced Aggravation of Nonalcoholic Fatty Liver Disease in Obese Mice Fed a High-Fat Diet. | 2017 | Details |
| A16020 | 28607535 | Mediators Inflamm | Gender Disparity in the Relationship between Prevalence of Thyroid Nodules and Metabolic Syndrome Components: The SHDC-CDPC Community-Based Study. | 2017 | Details |
| A16021 | 28606575 | Nutrition | Good adherence to the Mediterranean diet reduces the risk for NASH and diabetes in pediatric patients with obesity: The results of an Italian Study. | 2017 | Details |
| A16023 | 28605664 | J Nutr Biochem | Soy compared with milk protein in a Western diet changes fecal microbiota and decreases hepatic steatosis in obese OLETF rats. | 2017 | Details |
| A16024 | 28605159 | Obesity (Silver Spring) | Differential Impact of Weight Loss on Nonalcoholic Fatty Liver Resolution in a North American Cohort with Obesity. | 2017 | Details |
| A16025 | 28604704 | Nat Med | Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling. | 2017 | Details |
| A16027 | 28602867 | J Ethnopharmacol | Effect of Gangjihwan on hepatic steatosis and inflammation in high fat diet-fed mice. | 2017 | Details |
| A16030 | 28600319 | Physiol Genomics | Microbiome and NAFLD: potential influence of aerobic fitness and lifestyle modification. | 2017 | Details |
| A16032 | 28600116 | Surg Obes Relat Dis | Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy. | 2017 | Details |
| A16033 | 28599248 | Biomed Pharmacother | The multifaceted role of natriuretic peptides in metabolic syndrome. | 2017 | Details |
| A16034 | 28598982 | PLoS One | α-Mangostin ameliorates hepatic steatosis and insulin resistance by inhibition C-C chemokine receptor 2. | 2017 | Details |
| A16036 | 28598410 | Children (Basel) | Pediatric Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A16037 | 28598045 | J Assoc Physicians India | Soft Drinks Consumption and the Risk of Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16041 | 28596677 | World J Gastroenterol | Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease. | 2017 | Details |
| A16045 | 28595552 | Curr Med Chem | Pigment Epithelium-Derived Factor: A Novel Therapeutic Target for Cardiometabolic Diseases and Related Complications. | 2018 | Details |
| A16050 | 28593786 | Rev Esp Enferm Dig | Characterization of liver changes in ZSF1 rats, an animal model of metabolic syndrome. | 2017 | Details |
| A16054 | 28592311 | Trials | The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial. | 2017 | Details |
| A16056 | 28591572 | Cell Rep | Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans. | 2017 | Details |
| A16057 | 28591070 | J Clin Gastroenterol | Emerging Gastrointestinal and Liver Diseases in Asia Pacific: Implications to Health Care in the Region (World Gastroenterology Organization: Asian Pacific Association of Gastroenterology Distinguished Global Lecture 2015). | 2017 | Details |
| A16061 | 28587303 | Children (Basel) | The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A16063 | 28587078 | Nutrients | Morinda citrifolia Linn. (Noni) and Its Potential in Obesity-Related Metabolic Dysfunction. | 2017 | Details |
| A16065 | 28586417 | Fam Pract | Development and validation study of a non-alcoholic fatty liver disease risk scoring model among adults in China. | 2017 | Details |
| A16070 | 28585487 | Acta Chir Belg | Improvement of nonalcoholic fatty liver disease in morbidly obese patients after sleeve gastrectomy: association of ultrasonographic findings with lipid profile and liver enzymes. | 2017 | Details |
| A16073 | 28585211 | Adv Exp Med Biol | Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A16074 | 28585204 | Adv Exp Med Biol | Insulin Resistance, Obesity and Lipotoxicity. | 2017 | Details |
| A16077 | 28581332 | Future Cardiol | PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α. | 2017 | Details |
| A16079 | 28580850 | Orv Hetil | [Advances in the pathogenesis of non alcoholic fatty liver disease]. | 2017 | Details |
| A16080 | 28580278 | Mol Metab | FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis. | 2017 | Details |
| A16081 | 28579536 | Gastroenterology | Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity. | 2017 | Details |
| A16083 | 28578672 | Lipids Health Dis | Sake lees extract improves hepatic lipid accumulation in high fat diet-fed mice. | 2017 | Details |
| A16088 | 28577304 | Int J Cancer | The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: A study in the Swedish AMORIS cohort. | 2017 | Details |
| A16089 | 28577247 | Dig Dis Sci | Controlled Attenuation Parameter (CAP) with the XL Probe of the Fibroscan®: A Comparative Study with the M Probe and Liver Biopsy. | 2017 | Details |
| A16093 | 28574988 | PLoS One | The differing influence of several factors on the development of fatty liver with elevation of liver enzymes between genders with metabolic syndrome: A cross-sectional study. | 2017 | Details |
| A16098 | 28573064 | World J Gastrointest Pathophysiol | Nonalcoholic fatty liver disease: Diagnostic biomarkers. | 2017 | Details |
| A16100 | 28571771 | Food Chem Toxicol | The lemon balm extract ALS-L1023 inhibits obesity and nonalcoholic fatty liver disease in female ovariectomized mice. | 2017 | Details |
| A16102 | 28570941 | J Nutr Biochem | Diet-dependent retinoid effects on liver gene expression include stellate and inflammation markers and parallel effects of the nuclear repressor Shp. | 2017 | Details |
| A16105 | 28570343 | Eur J Gastroenterol Hepatol | Controlled attenuation parameter for diagnosing steatosis in bariatric surgery candidates with suspected nonalcoholic fatty liver disease. | 2017 | Details |
| A16106 | 28567448 | Sci Immunol | Type I Interferon Responses Drive Intrahepatic T cells to Promote Metabolic Syndrome. | 2017 | Details |
| A16107 | 28566439 | Eur J Endocrinol | MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease. | 2017 | Details |
| A16108 | 28566408 | J Mol Endocrinol | 5-ALA ameliorates hepatic steatosis through AMPK signaling pathway. | 2017 | Details |
| A16110 | 28562737 | Sao Paulo Med J | Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review. | 2017 | Details |
| A16111 | 28562560 | Medicine (Baltimore) | Triglyceride glucose-body mass index is effective in identifying nonalcoholic fatty liver disease in nonobese subjects. | 2017 | Details |
| A16113 | 28560633 | Indian J Gastroenterol | Simultaneous living donor liver transplant with sleeve gastrectomy for metabolic syndrome and NASH-related ESLD-First report from India. | 2017 | Details |